製品名:2-(4-iodopentyl)isoindole-1,3-dione

IUPAC Name:2-(4-iodopentyl)-2,3-dihydro-1H-isoindole-1,3-dione

CAS番号:63460-47-9
分子式:C13H14INO2
純度:95%+
カタログ番号:CM341453
分子量:343.16

包装単位 有効在庫 価格(USD) 数量

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:63460-47-9
分子式:C13H14INO2
融点:-
SMILESコード:O=C1N(CCCC(I)C)C(C2=C1C=CC=C2)=O
密度:
カタログ番号:CM341453
分子量:343.16
沸点:
MDL番号:
保管方法:

Column Infos

Tafenoquine
60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.